MLex Comment: Merck, Schering-Plough EC review likely to focus on animal health and asthma markets
A first look at Merck’s acquisition of Schering-Plough reveals that Merck may have to divest some animal health offerings, in the context of an eventual European Commission review of the transaction....To view the full article, register now.
Already a subscriber? Click here to view full article